Tricyclic antidepressants (TCAs) appear on drug tests primarily because they carry a high risk of fatal overdose, not because they’re controlled substances. Unlike the standard 5-panel workplace drug test (which screens for marijuana, cocaine, opioids, amphetamines, and PCP), a TCA screen is typically ordered in emergency rooms or hospital settings when a doctor suspects poisoning or needs to monitor safe dosing. If you’ve seen TCAs listed on a broader panel, it’s because the gap between an effective dose and a dangerous one is unusually small.
Why TCAs Get Their Own Screen
TCAs are one of the leading causes of prescription drug overdose deaths in the United States. The reason comes down to how these medications work in the body. At therapeutic doses, they help with depression, chronic pain, and certain sleep disorders. But slightly above that range, they can disrupt the heart’s electrical system, triggering dangerous rhythm problems and seizures. This narrow margin of safety is why hospitals need a fast way to detect them.
A TCA screen is most commonly used in two situations: monitoring patients who are already taking the medication to make sure blood levels stay in a safe range, and diagnosing a suspected overdose in an emergency. Symptoms of TCA toxicity include dry mouth, blurred vision, drowsiness, confusion, tremors, seizures, and difficulty urinating. Because cardiac complications can escalate quickly, identifying a TCA overdose early is genuinely lifesaving.
How TCA Overdose Affects the Heart
The main danger of TCA toxicity is cardiac. These drugs block sodium channels in heart muscle cells, which slows the electrical signals that keep the heart beating in rhythm. On an EKG, this shows up as a widened QRS complex. When that measurement exceeds 100 milliseconds, it predicts seizures. Above 160 milliseconds, it predicts life-threatening arrhythmias. TCAs also block potassium channels, which can lead to a separate type of dangerous heart rhythm called torsades de pointes.
This is the core reason TCAs are screened for in medical settings. A patient who arrives at an emergency room unconscious or confused may have taken any number of substances. Knowing whether TCAs are involved changes treatment decisions immediately.
TCAs on Workplace or Employment Drug Tests
Standard workplace drug panels do not typically include TCAs. The common 5-panel and 10-panel tests used by employers focus on illegal drugs and commonly abused prescription medications like opioids and benzodiazepines. TCAs are legal prescription medications, and taking one as prescribed would not normally be flagged in pre-employment or random workplace screening.
However, some extended panels (12-panel or broader) do include a TCA line, particularly for safety-sensitive positions. If you’re taking a prescribed TCA and it shows up on one of these expanded tests, you can typically resolve it by providing documentation from your prescribing doctor. The presence of TCAs on a panel doesn’t mean they’re classified as drugs of abuse. It reflects the overdose risk and the fact that impairment from these medications can affect alertness and reaction time.
Aviation and Transportation Rules
For pilots, air traffic controllers, and commercial drivers, TCA use gets more scrutiny. The FAA does not include tricyclic antidepressants on its list of conditionally acceptable medications. While certain SSRIs can be approved on a case-by-case basis after at least three months of stable use and a specialized evaluation, TCAs carry more sedation and cardiac risk, making them harder to clear for safety-sensitive aviation roles. If you hold an FAA medical certificate, switching to or from any antidepressant requires coordination with an aviation medical examiner.
False Positives Are Common
One of the most frustrating aspects of TCA screening is the high rate of false positives. The initial test used in most settings is an immunoassay, a quick, inexpensive method that identifies drugs by their chemical shape. The problem is that several other common medications have a structure similar enough to TCAs to trigger a positive result even when no TCA is present.
Medications known to cause false-positive TCA results include:
- Diphenhydramine (Benadryl), an over-the-counter allergy and sleep medication
- Cyclobenzaprine (Flexeril), a muscle relaxant
- Carbamazepine (Tegretol), a seizure medication
- Quetiapine (Seroquel), an antipsychotic
- Hydroxyzine (Vistaril), an anti-anxiety and antihistamine medication
- Cyproheptadine, an antihistamine used for appetite stimulation
Diphenhydramine is especially worth noting because it’s available without a prescription and widely used. Multiple case reports have documented false-positive TCA results in patients who overdosed on diphenhydramine alone. If emergency doctors treat for TCA toxicity based on a false positive, it can delay the correct treatment.
What Happens After a Positive Result
An initial positive TCA screen is never considered definitive on its own. Confirmatory testing uses more precise laboratory methods, most commonly gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry. These techniques can identify exactly which TCA or metabolite is present in the sample and measure its concentration, ruling out false positives from other medications.
In a medical emergency, doctors won’t wait for confirmatory results before starting treatment. They’ll act on the initial screen combined with symptoms and EKG findings. In a workplace or legal testing context, however, the confirmatory test is what determines the final result. If your initial screen comes back positive and you haven’t taken a TCA, requesting confirmation testing will typically clear the result.
If you’re taking a prescribed TCA and are facing any type of drug screening, keeping a record of your prescription and dose is the simplest way to address a positive result before it becomes a concern.